» Articles » PMID: 11996816

An in Vitro Mucosal Model for Prediction of the Bioadhesion of Alginate Solutions to the Oesophagus

Overview
Journal Int J Pharm
Specialties Chemistry
Pharmacology
Date 2002 May 9
PMID 11996816
Citations 13
Authors
Affiliations
Soon will be listed here.
Abstract

This paper discusses the development of an in vitro model utilised to assess the adhesion of alginate solutions to porcine oesophageal tissue. The methodology involved the construction of retention apparatus onto which sections of tissue were mounted. Fluorescently labelled alginate solutions of known rheological profile were dispensed onto the tissue at a concentration of 2% w/v. A washing solution was applied at a specified rate to mimic saliva flow and the eluted material collected. Fluorimetric analysis allowed dose retention to be assessed as a function of time. The effect of the nature of the washing solution and the choice of alginate were investigated. It was found that after 30 min up to 20% of the applied alginate dose remained associated with the tissue, regardless of the alginate selected from the range examined. The nature of the washing medium did not have a significant effect on retention, irrespective of the inherent mucin concentration. Overall this study indicated that the technique presented offers a viable means of studying bioadhesion of liquids and also demonstrates that alginate solutions may have an application as bioadhesive agents for localisation within the oesophagus.

Citing Articles

Biopolymer Drug Delivery Systems for Oromucosal Application: Recent Trends in Pharmaceutical R&D.

Dubashynskaya N, Petrova V, Skorik Y Int J Mol Sci. 2024; 25(10).

PMID: 38791397 PMC: 11120705. DOI: 10.3390/ijms25105359.


Current status and advances in esophageal drug delivery technology: influence of physiological, pathophysiological and pharmaceutical factors.

Lim A, Talley N, Walker M, Storm G, Hua S Drug Deliv. 2023; 30(1):2219423.

PMID: 37344759 PMC: 10286676. DOI: 10.1080/10717544.2023.2219423.


Barrier effect and wound healing activity of the medical device REF-FTP78 in the treatment of gastroesophageal reflux disease.

Pecora T, Parisi O, Bertin W, Ragazzo B, Dattilo M, Scigliano N Sci Rep. 2022; 12(1):6136.

PMID: 35414705 PMC: 9005723. DOI: 10.1038/s41598-022-10171-6.


A novel porcine model of acid-induced esophageal damage for preliminary functional evaluations of anti-gastroesophageal reflux disease medical devices.

Ventrella D, Salaroli R, Elmi A, Carnevali G, Forni M, Baldi F Vet World. 2021; 13(12):2728-2735.

PMID: 33487991 PMC: 7811544. DOI: 10.14202/vetworld.2020.2728-2735.


Barrier Effect of a New Topical Agent on Damaged Esophageal Mucosa: Experimental Study on an ex vivo Swine Model.

Salaroli R, Ventrella D, Bernardini C, Elmi A, Zannoni A, Bacci M Clin Exp Gastroenterol. 2020; 13:569-576.

PMID: 33223844 PMC: 7671490. DOI: 10.2147/CEG.S269568.